Arthur F. Ryan - 01 Feb 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Issuer symbol
REGN
Transactions as of
01 Feb 2023
Net transactions value
-$75,613
Form type
4
Filing time
03 Feb 2023, 15:15:24 UTC
Previous filing
05 Jan 2023
Next filing
03 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $1,504 -2 -0.01% $752.11 19,345 01 Feb 2023 Direct F1, F2
transaction REGN Common Stock Sale $13,564 -18 -0.09% $753.54 19,327 01 Feb 2023 Direct F1, F3
transaction REGN Common Stock Sale $12,826 -17 -0.09% $754.45 19,310 01 Feb 2023 Direct F1, F4
transaction REGN Common Stock Sale $12,844 -17 -0.09% $755.50 19,293 01 Feb 2023 Direct F1, F5
transaction REGN Common Stock Sale $18,162 -24 -0.12% $756.77 19,269 01 Feb 2023 Direct F1, F6
transaction REGN Common Stock Sale $1,515 -2 -0.01% $757.29 19,267 01 Feb 2023 Direct F1, F7
transaction REGN Common Stock Sale $5,310 -7 -0.04% $758.58 19,260 01 Feb 2023 Direct F1, F8
transaction REGN Common Stock Sale $3,039 -4 -0.02% $759.65 19,256 01 Feb 2023 Direct F1, F9
transaction REGN Common Stock Sale $3,042 -4 -0.02% $760.40 19,252 01 Feb 2023 Direct F1, F10
transaction REGN Common Stock Sale $2,285 -3 -0.02% $761.58 19,249 01 Feb 2023 Direct F1, F11
transaction REGN Common Stock Sale $1,524 -2 -0.01% $762.17 19,247 01 Feb 2023 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $752.02 to $752.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
F3 Represents volume-weighted average price of sales of 18 shares of Company stock on February 1, 2023 at prices ranging from $753.05 to $753.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
F4 Represents volume-weighted average price of sales of 17 shares of Company stock on February 1, 2023 at prices ranging from $754.08 to $754.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
F5 Represents volume-weighted average price of sales of 17 shares of Company stock on February 1, 2023 at prices ranging from $755.11 to $755.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
F6 Represents volume-weighted average price of sales of 24 shares of Company stock on February 1, 2023 at prices ranging from $756.18 to $756.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
F7 Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $757.02 to $757.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
F8 Represents volume-weighted average price of sales of 7 shares of Company stock on February 1, 2023 at prices ranging from $758.29 to $758.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
F9 Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2023 at prices ranging from $759.30 to $759.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
F10 Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2023 at prices ranging from $760.09 to $760.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
F11 Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2023 at prices ranging from $761.49 to $761.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
F12 Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $762.15 to $762.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.